Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in PROTAGONIST THERAPEUTICS INC
DRIEHAUS CAPITAL MANAGEMENT LLC holds 1.1M shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $96M as of 2025-Q4. The position was decreased (-3.6% shares). PTGX represents 0.7% of DRIEHAUS CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$96M
Current Shares
1.1M
Total Value Change
+$76.7M
Total Shares Change
+542,335
Other major holders of PTGX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, CAPITAL FUND MANAGEMENT S.A.
Decreased |
| 1.1M |
-3.6% |
| $96M |
| 0.7% |
| $87.26 |
0 |
| 2025-Q3 | Increased | 1.1M | +50.4% | $75.7M | 0.5% | $65.14 | 58 |
| 2025-Q2 | Increased | 757,710 | +222.3% | $41.9M | 0.3% | $55.69 | 56 |
| 2025-Q1 | Decreased | 235,073 | -30.8% | $11.4M | 0.1% | $48.88 | 0 |
| 2024-Q4 | Decreased | 339,698 | -23.7% | $13.1M | 0.1% | $38.51 | 0 |
| 2024-Q3 | Decreased | 445,352 | -20.0% | $20M | 0.2% | $44.56 | 0 |
| 2024-Q2 | Decreased | 556,835 | -0.7% | $19.3M | 0.2% | $34.65 | 0 |